Checkpoint modulation in chronic hepatitis B: From hypothesis to approval

Affiliations

¹ First Department of Internal Medicine, Gastroenterology and Hepatology Section, AHEPA Hospital of the Aristotle University Medical School, Thessaloniki, Greece.
² Department of Pathology, AHEPA Hospital of the Aristotle University Medical School, Thessaloniki, Greece.
³ Third Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁴ Department of Immunology and Histocompatibility, University of Thessaly, School of Health Sciences, Faculty of Medicine, Larissa, Greece.

Comment

Georgios Germanidis et al. Hepatology. 2018 Mar.

. 2018 Mar;67(3):1175-1176.

doi: 10.1002/hep.29695. Epub 2018 Jan 30.

¹ First Department of Internal Medicine, Gastroenterology and Hepatology Section, AHEPA Hospital of the Aristotle University Medical School, Thessaloniki, Greece.
² Department of Pathology, AHEPA Hospital of the Aristotle University Medical School, Thessaloniki, Greece.
³ Third Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁴ Department of Immunology and Histocompatibility, University of Thessaly, School of Health Sciences, Faculty of Medicine, Larissa, Greece.

No abstract available

Comment on

Hepatitis B cure: From discovery to regulatory approval.
Lok AS, Zoulim F, Dusheiko G, Ghany MG. Lok AS, et al. Hepatology. 2017 Oct;66(4):1296-1313. doi: 10.1002/hep.29323. Epub 2017 Aug 1. Hepatology. 2017. PMID: 28762522 Free PMC article.